(+)-alpha-tocopherol multiple interactions EXP 6480464 [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein], [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:19595682 , PMID:21535577 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LCAT mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:20024955 (25R)-cholest-5-ene-3beta,26-diol increases metabolic processing ISO RGD:737383 6480464 LCAT protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:7744831 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA CTD PMID:18465118 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10859 6480464 Tetrachlorodibenzodioxin results in decreased expression of LCAT mRNA CTD PMID:28213091 , PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10859 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LCAT gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10859 6480464 Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10859 6480464 Tetrachlorodibenzodioxin affects the expression of LCAT mRNA CTD PMID:21570461 2-amino-2-deoxy-D-galactopyranose decreases activity EXP 6480464 Galactosamine results in decreased activity of LCAT protein CTD PMID:6631239 26-hydroxycholesterol increases metabolic processing ISO RGD:737383 6480464 LCAT protein results in increased metabolism of 27-hydroxycholesterol CTD PMID:7744831 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of LCAT mRNA CTD PMID:11328961 4-hydroxynon-2-enal decreases expression ISO RGD:737383 6480464 4-hydroxy-2-nonenal results in decreased expression of LCAT mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:10859 6480464 Fenretinide results in increased expression of LCAT mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:737383 6480464 Decitabine affects the expression of LCAT mRNA CTD PMID:23300844 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of LCAT mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of LCAT mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of LCAT mRNA CTD PMID:25825206 aflatoxin B1 decreases expression ISO RGD:10859 6480464 Aflatoxin B1 results in decreased expression of LCAT mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:737383 6480464 Aflatoxin B1 results in decreased expression of LCAT mRNA CTD PMID:27153756 alliin multiple interactions EXP 6480464 alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:16640830 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of LCAT mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LCAT mRNA CTD PMID:16483693 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin inhibits the reaction [[Cholesterol co-treated with Cholic Acid] results in increased activity of LCAT protein] CTD PMID:30273964 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of LCAT mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:10859 6480464 Benzo(a)pyrene results in decreased expression of LCAT mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:737383 6480464 Benzo(a)pyrene results in decreased expression of LCAT mRNA CTD PMID:26238291 benzo[a]pyrene diol epoxide I increases expression ISO RGD:737383 6480464 7 more ... CTD PMID:20382639 bis(2-chloroethyl) sulfide increases expression ISO RGD:10859 6480464 Mustard Gas results in increased expression of LCAT mRNA CTD PMID:15674843 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LCAT mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LCAT mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:737383 6480464 bisphenol A affects the expression of LCAT mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:10859 6480464 bisphenol A results in decreased methylation of LCAT promoter CTD PMID:27312807 cadmium atom decreases activity EXP 6480464 Cadmium results in decreased activity of LCAT protein CTD PMID:21535577 cadmium atom multiple interactions EXP 6480464 [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein] more ... CTD PMID:21535577 , PMID:25240712 carbon nanotube increases expression ISO RGD:10859 6480464 Nanotubes, Carbon analog results in increased expression of LCAT mRNA, Nanotubes, Carbon results in increased expression of LCAT mRNA CTD PMID:25620056 chlorogenic acid multiple interactions EXP 6480464 [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein], Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein] CTD PMID:20696151 cholesterol increases acylation ISO RGD:737383 6480464 LCAT protein results in increased acylation of Cholesterol CTD PMID:4847537 cholesterol multiple interactions EXP 6480464 [Cholesterol co-treated with Cholic Acid] results in increased activity of LCAT protein more ... CTD PMID:30273964 cholic acid multiple interactions EXP 6480464 [Cholesterol co-treated with Cholic Acid] results in increased activity of LCAT protein more ... CTD PMID:30273964 choline increases expression ISO RGD:10859 6480464 Choline results in increased expression of LCAT mRNA CTD PMID:25178843 choline multiple interactions ISO RGD:10859 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of LCAT mRNA CTD PMID:25178843 cisplatin affects expression ISO RGD:737383 6480464 Cisplatin affects the expression of LCAT mRNA CTD PMID:23300844 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of LCAT mRNA CTD PMID:19483382 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of LCAT mRNA CTD PMID:11328961 clofibrate multiple interactions ISO RGD:10859 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:10859 6480464 Clofibrate results in decreased expression of LCAT mRNA CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of LCAT mRNA CTD PMID:17602206 copper atom decreases activity ISO RGD:737383 6480464 Copper results in decreased activity of LCAT protein CTD PMID:7751820 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of LCAT mRNA, Copper results in increased expression of LCAT mRNA CTD PMID:19821111 , PMID:30556269 copper(0) decreases activity ISO RGD:737383 6480464 Copper results in decreased activity of LCAT protein CTD PMID:7751820 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of LCAT mRNA, Copper results in increased expression of LCAT mRNA CTD PMID:19821111 , PMID:30556269 copper(II) chloride increases expression ISO RGD:10859 6480464 cupric chloride results in increased expression of LCAT mRNA CTD PMID:17211630 copper(II) sulfate decreases expression ISO RGD:737383 6480464 Copper Sulfate results in decreased expression of LCAT mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:737383 6480464 Cyclosporine results in decreased expression of LCAT mRNA CTD PMID:25562108 , PMID:27989131 D-gluconic acid multiple interactions EXP 6480464 [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA] CTD PMID:30031400 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of LCAT mRNA CTD PMID:18636392 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of LCAT mRNA CTD PMID:18636392 dichlorvos decreases activity ISO RGD:737383 6480464 Dichlorvos results in decreased activity of LCAT protein CTD PMID:4847537 dichlorvos multiple interactions ISO RGD:737383 6480464 Dichlorvos inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] CTD PMID:4847537 dioleoyl phosphatidylcholine affects binding ISO RGD:737383 6480464 LCAT protein binds to 1, 2-oleoylphosphatidylcholine CTD PMID:16780378 disodium selenite multiple interactions EXP 6480464 [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA] CTD PMID:30031400 doxorubicin increases expression ISO RGD:10859 6480464 Doxorubicin results in increased expression of LCAT mRNA CTD PMID:26873546 elemental selenium multiple interactions EXP 6480464 [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA] CTD PMID:30031400 ethanol multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in decreased activity of LCAT protein] CTD PMID:28442378 ethanol increases expression ISO RGD:10859 6480464 Ethanol results in increased expression of LCAT mRNA CTD PMID:30319688 ethanol decreases activity EXP 6480464 Ethanol results in decreased activity of LCAT protein CTD PMID:28442378 ethyl methanesulfonate increases expression ISO RGD:737383 6480464 Ethyl Methanesulfonate results in increased expression of LCAT mRNA CTD PMID:23649840 fenitrothion multiple interactions ISO RGD:737383 6480464 Fenitrothion inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] CTD PMID:4847537 fenitrothion decreases activity ISO RGD:737383 6480464 Fenitrothion results in decreased activity of LCAT protein CTD PMID:4847537 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of LCAT mRNA CTD PMID:18035473 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of LCAT mRNA CTD PMID:18035473 formaldehyde increases expression ISO RGD:737383 6480464 Formaldehyde results in increased expression of LCAT mRNA CTD PMID:23649840 fumonisin B1 decreases expression ISO RGD:10859 6480464 fumonisin B1 results in decreased expression of LCAT mRNA CTD PMID:16221962 furan decreases expression EXP 6480464 furan results in decreased expression of LCAT mRNA CTD PMID:15120968 hydrogen peroxide decreases expression ISO RGD:737383 6480464 Hydrogen Peroxide results in decreased expression of LCAT mRNA CTD PMID:12419474 isoprenaline multiple interactions EXP 6480464 [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] more ... CTD PMID:15740881 more ... isoprenaline decreases activity EXP 6480464 Isoproterenol results in decreased activity of LCAT protein CTD PMID:15740881 more ... L-ethionine affects expression EXP 6480464 Ethionine affects the expression of LCAT mRNA CTD PMID:19483382 L-methionine multiple interactions ISO RGD:10859 6480464 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of LCAT mRNA CTD PMID:25178843 linoleic acid increases expression ISO RGD:10859 6480464 Linoleic Acid analog results in increased expression of LCAT mRNA CTD PMID:27939595 lipopolysaccharide decreases expression ISO RGD:10859 6480464 Lipopolysaccharides results in decreased expression of LCAT mRNA CTD PMID:12057914 lithocholic acid decreases expression ISO RGD:10859 6480464 Lithocholic Acid results in decreased expression of LCAT mRNA CTD PMID:20359477 lithocholic acid multiple interactions ISO RGD:10859 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LCAT mRNA CTD PMID:20359477 magnesium atom multiple interactions EXP 6480464 [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA] CTD PMID:30031400 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of LCAT mRNA CTD PMID:28801915 methyl methanesulfonate increases expression ISO RGD:737383 6480464 Methyl Methanesulfonate results in increased expression of LCAT mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:737383 6480464 methylmercuric chloride results in increased expression of LCAT mRNA CTD PMID:28001369 myricetin multiple interactions EXP 6480464 myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of LCAT protein] CTD PMID:25240712 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of LCAT mRNA CTD PMID:19638242 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:16906524 nevirapine increases expression ISO RGD:737383 6480464 Nevirapine results in increased expression of LCAT protein CTD PMID:19667106 Niclosamide increases expression ISO RGD:737383 6480464 Niclosamide results in increased expression of LCAT mRNA CTD PMID:28284560 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein more ... CTD PMID:20696151 obeticholic acid decreases expression ISO RGD:737383 6480464 obeticholic acid results in decreased expression of LCAT mRNA CTD PMID:27939613 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of LCAT mRNA CTD PMID:19483382 orlistat multiple interactions EXP 6480464 orlistat inhibits the reaction [Dietary Fats results in decreased expression of LCAT protein] CTD PMID:25087745 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of LCAT mRNA CTD PMID:18636392 paracetamol multiple interactions ISO RGD:10859 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:737383 6480464 Acetaminophen results in increased expression of LCAT mRNA CTD PMID:21420995 parathion-methyl decreases activity ISO RGD:737383 6480464 Methyl Parathion results in decreased activity of LCAT protein CTD PMID:4847537 parathion-methyl multiple interactions ISO RGD:737383 6480464 Methyl Parathion inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] CTD PMID:4847537 perfluorohexanesulfonic acid decreases expression ISO RGD:10859 6480464 perfluorohexanesulfonic acid results in decreased expression of LCAT mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10859 6480464 perfluorooctane sulfonic acid results in decreased expression of LCAT mRNA CTD PMID:21705711 perfluorooctanoic acid decreases expression ISO RGD:10859 6480464 perfluorooctanoic acid results in decreased expression of LCAT mRNA CTD PMID:17681415 , PMID:30657992 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of LCAT mRNA CTD PMID:19162173 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of LCAT mRNA CTD PMID:19162173 phenytoin increases expression ISO RGD:10859 6480464 Phenytoin results in increased expression of LCAT mRNA CTD PMID:15136057 piperine multiple interactions EXP 6480464 piperine inhibits the reaction [Dietary Fats results in decreased expression of LCAT protein] CTD PMID:25087745 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of LCAT mRNA CTD PMID:19483382 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of LCAT mRNA CTD PMID:19162173 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LCAT mRNA CTD PMID:16940010 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:10859 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LCAT mRNA CTD PMID:20359477 proanthocyanidin multiple interactions EXP 6480464 Proanthocyanidins inhibits the reaction [[Cholesterol co-treated with Cholic Acid] results in increased activity of LCAT protein] CTD PMID:30273964 quercetin multiple interactions EXP 6480464 [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein], [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:19595682 , PMID:21535577 quercetin affects expression ISO RGD:737383 6480464 Quercetin affects the expression of LCAT mRNA CTD PMID:21632981 resveratrol decreases expression ISO RGD:10859 6480464 resveratrol results in decreased expression of LCAT mRNA CTD PMID:19028542 selenium atom multiple interactions EXP 6480464 [[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA] CTD PMID:30031400 silicon dioxide increases expression ISO RGD:737383 6480464 Silicon Dioxide results in increased expression of LCAT mRNA CTD PMID:25351596 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of LCAT mRNA CTD PMID:25055962 simvastatin increases activity ISO RGD:10859 6480464 Simvastatin results in increased activity of LCAT protein CTD PMID:21241519 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of LCAT mRNA CTD PMID:25697676 sodium fluoride increases expression ISO RGD:10859 6480464 Sodium Fluoride results in increased expression of LCAT mRNA CTD PMID:27862939 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Cadmium] results in decreased activity of LCAT protein more ... CTD PMID:20696151 , PMID:25240712 tert-butyl hydroperoxide decreases expression ISO RGD:737383 6480464 tert-Butylhydroperoxide results in decreased expression of LCAT mRNA CTD PMID:12419474 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LCAT mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LCAT mRNA] CTD PMID:31150632 tetracycline decreases expression ISO RGD:10859 6480464 Tetracycline results in decreased expression of LCAT mRNA CTD PMID:24489787 tetrahydrocurcumin multiple interactions EXP 6480464 [tetrahydrocurcumin co-treated with Chlorogenic Acid] results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein], tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein] CTD PMID:20696151 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of LCAT mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LCAT mRNA CTD PMID:26222700 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of LCAT mRNA CTD PMID:30012374 tris(2-butoxyethyl) phosphate affects expression ISO RGD:737383 6480464 tris(2-butoxyethyl) phosphate affects the expression of LCAT mRNA CTD PMID:29024780 tunicamycin increases expression ISO RGD:737383 6480464 Tunicamycin results in increased expression of LCAT mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:737383 6480464 Urethane results in decreased expression of LCAT mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:10859 6480464 Valproic Acid affects the expression of LCAT mRNA CTD PMID:17292431 valproic acid increases methylation ISO RGD:737383 6480464 Valproic Acid results in increased methylation of LCAT gene CTD PMID:29154799 , PMID:29501571 valproic acid decreases expression ISO RGD:737383 6480464 Valproic Acid results in decreased expression of LCAT mRNA CTD PMID:29154799 , PMID:29501571 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LCAT mRNA CTD PMID:22570695 vitamin E multiple interactions EXP 6480464 [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein], [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] CTD PMID:19595682 , PMID:21535577 zinc atom affects expression EXP 6480464 Zinc affects the expression of LCAT mRNA CTD PMID:16413754 zinc(0) affects expression EXP 6480464 Zinc affects the expression of LCAT mRNA CTD PMID:16413754 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [Ethanol results in decreased activity of LCAT protein] CTD PMID:28442378
Biological Process cholesterol esterification ISO RGD:737383 1624291 (PMID:26195816), (PMID:3458198), (PMID:4335615) RGD PMID:26195816 more ... cholesterol esterification ISS UniProtKB:P04180 1600115 GO_REF:0000024 UniProt GO_REF:0000024 cholesterol esterification IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol homeostasis ISO RGD:737383 1624291 (PMID:4335615) RGD PMID:4335615 cholesterol homeostasis IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol metabolic process IDA 1581789 RGD cholesterol metabolic process IEA UniProtKB:P16301 , ensembl:ENSMUSP000000382321600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol metabolic process IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 cholesterol metabolic process ISO RGD:737383 1624291 (PMID:10559507), (PMID:26195816), (PMID:4335615) RGD PMID:10559507 more ... cholesterol metabolic process ISO RGD:10859 1624291 (MGI:MGI:1096057, PMID:9300780) RGD MGI:MGI:1096057 , PMID:9300780 cholesterol transport ISO RGD:737383 1624291 (PMID:10559507) RGD PMID:10559507 high-density lipoprotein particle remodeling ISO RGD:737383 1624291 (PMID:10722751), (PMID:12167653), (PMID:15210842), (PMID:4335615) RGD PMID:10722751 more ... high-density lipoprotein particle remodeling IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipoprotein biosynthetic process ISO RGD:10859 1624291 (MGI:MGI:3616112, PMID:16245952) RGD MGI:MGI:3616112 , PMID:16245952 lipoprotein biosynthetic process IEA UniProtKB:P16301 , ensembl:ENSMUSP000000382321600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipoprotein metabolic process IDA 1581794 RGD phosphatidylcholine biosynthetic process ISO RGD:737383 1624291 (PMID:11966470) RGD PMID:11966470 phosphatidylcholine biosynthetic process IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 phosphatidylcholine metabolic process ISO RGD:737383 1624291 (PMID:26195816) RGD PMID:26195816 phosphatidylcholine metabolic process ISS UniProtKB:P04180 1600115 GO_REF:0000024 UniProt GO_REF:0000024 phospholipid metabolic process ISO RGD:737383 1624291 (PMID:4335615) RGD PMID:4335615 regulation of high-density lipoprotein particle assembly IEA UniProtKB:P16301 , ensembl:ENSMUSP000000382321600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of high-density lipoprotein particle assembly ISO RGD:10859 1624291 (MGI:MGI:3848791, PMID:19065001) RGD MGI:MGI:3848791 , PMID:19065001 response to copper ion IDA 1581777 RGD response to glucocorticoid IDA 1581770 RGD reverse cholesterol transport ISO RGD:737383 1624291 (PMID:4335615) RGD PMID:4335615 reverse cholesterol transport IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 very-low-density lipoprotein particle remodeling ISO RGD:737383 1624291 (PMID:15654758) RGD PMID:15654758 very-low-density lipoprotein particle remodeling IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cellular Component extracellular region IEA UniProtKB-SubCell:SL-0243 1600115 GO_REF:0000039 UniProt GO_REF:0000039 extracellular space ISO RGD:10859 1624291 (MGI:MGI:1352057, PMID:10549415) RGD MGI:MGI:1352057 , PMID:10549415 extracellular space ISO RGD:737383 1624291 (PMID:10559507), (PMID:3458198), (PMID:4335615) RGD PMID:10559507 more ... high-density lipoprotein particle ISO RGD:737383 1624291 (PMID:3104518) RGD PMID:3104518 high-density lipoprotein particle IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function apolipoprotein A-I binding ISO RGD:737383 1624291 UniProtKB:P02647 (PMID:1587806) RGD PMID:1587806 apolipoprotein A-I binding IEA UniProtKB:P04180 , ensembl:ENSP000002640051600115 GO_REF:0000107 Ensembl GO_REF:0000107 phosphatidylcholine-sterol O-acyltransferase activity IDA 729077 RGD phosphatidylcholine-sterol O-acyltransferase activity IEA EC:2.3.1.43 1600115 GO_REF:0000003 UniProt GO_REF:0000003 phosphatidylcholine-sterol O-acyltransferase activity ISO RGD:10859 1624291 (MGI:MGI:1096057 more ... RGD MGI:MGI:1096057 more ... phosphatidylcholine-sterol O-acyltransferase activity ISO RGD:737383 1624291 (PMID:10559507), (PMID:26195816), (PMID:4335615) RGD PMID:10559507 more ... phospholipase A2 activity IDA 729077 RGD protein binding ISO RGD:737383 1624291 UniProtKB:P01023 , UniProtKB:P02647 (PMID:11435418), (PMID:1587806), (PMID:17676061) RGD PMID:11435418 more ...
Gene-Chemical Interaction Annotations
